6505--766-25-1-400-0289 -Charleston CMOP CLOMIPHENE CITRATE -(VA-25-00034392)
ID: 36C77025Q0121Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/4c632366ddd9452da4d910baf598171d/view
Timeline
    Description

    The Department of Veterans Affairs is preparing to procure CloMiphene Citrate 50mg tablets for its Charleston Consolidated Mail Outpatient Pharmacy (CMOP). The procurement seeks a total of 720 units, packaged in boxes of 30, with a focus on compliance with the Drug Supply Chain Security Act, requiring vendors to provide proof of state wholesale distributor licensure. This pharmaceutical product is crucial for supporting the health needs of veterans, ensuring they receive necessary medications in a timely manner. Interested small business vendors must submit their proposals by February 20, 2025, with the estimated issue date for the solicitation being February 13, 2025. Proposals should be sent via email to Contract Specialist Jennifer Coleman at Jennifer.Coleman4@va.gov, and must include signed solicitation cover pages, price schedules in Excel format, and certifications regarding the Buy American Act.

    Point(s) of Contact
    Jennifer D ColemanContract Specialist
    jennifer.coleman4@va.gov
    Files
    Title
    Posted
    36C77025Q0121_1.docx
    The Department of Veterans Affairs, Network Contracting Office 15, is preparing to procure CloMiphene Citrate 50mg tablets for its Charleston Consolidated Mail Outpatient Pharmacy (CMOP). The presolicitation notice outlines the requirement, including an estimated issue date of February 13, 2025, and a response due date of February 20, 2025. A total of 720 units are sought, packaged in boxes of 30. This procurement is designated as a Small Business Set-Aside, inviting only small business vendors to submit bids. Interested vendors must comply with the Drug Supply Chain Security Act, providing proof of state wholesale distributor licensure with their quotations. Submissions will include signed solicitation cover pages, price schedules in Excel format, and certifications regarding the Buy American Act. Proposals are to be sent via email to the provided contact, Jennifer Coleman. The notice emphasizes that timely submissions will be considered. Overall, it illustrates the VA's structured procurement process for pharmaceuticals, ensuring adherence to regulatory compliance while supporting the needs of veterans.
    36C77025Q0121.docx
    The document outlines a federal solicitation for pharmaceutical supplies by the Department of Veterans Affairs (VA), specifically addressing the Charleston Consolidated Mail Outpatient Pharmacy (CMOP). It includes key details such as the contract number, solicitation number, offer due date, and required submissions, emphasizing the necessity for compliance with guidelines stipulated in various federal regulations. The document specifies criteria regarding eligibility for small businesses, delivery terms, invoicing processes, product quality standards, and bar coding requirements for pharmaceuticals. Highlighting the importance of accurate and timely delivery, vendors are instructed to provide a firm commitment for product availability and pricing shortly before purchase orders are finalized. Provisions for handling recalls and ensuring compliance with the Drug Supply Chain Security Act are also detailed. The document establishes clear expectations for contractors, including product specifications, acceptable packaging, and legal obligations regarding product recalls. Additionally, it mandates electronic payment processes for invoicing. Overall, this solicitation exemplifies the structured nature of government procurement processes, emphasizing compliance, quality control, and the need for transparency in bidding and fulfillment in the pharmaceutical sector.
    S02 - Pricing Schedule - Q0121 - Charleston.xlsx
    The Charleston CMOP has issued a Request for Quotation (RFQ): 3677025Q0121, aimed at procuring CLOMIPHENE CITRATE 50MG tablets in a specified quantity of 720 at the facility. Quotes must be submitted by February 20, 2025, at 3:00 PM Central Time. Vendors are required to complete a signed SF1449 solicitation cover page, provide a quote spreadsheet, and maintain valid State Wholesale Distributor Licenses. All submissions should adhere to the Buy American Act requirements and include pertinent vendor comments regarding pharmaceutical expiration dates, ensuring they meet the minimum one-year shelf life from delivery. The document specifies submission procedures, including emailing quotes to the designated point of contact, Jennifer Coleman, and limits each vendor to one quote submission. The structure encompasses sections for item description, quantity, unit price, and total price, (yet it currently lists prices as $0.00). This RFQ reflects the procurement process within government RFPs, emphasizing compliance, documentation, and specific delivery requirements for medical supplies.
    Similar Opportunities
    6515--766-25-1-400-0207 -Charleston CMOP RESERVOR/SLIM -(VA-25-00028367)
    Buyer not available
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for the procurement of a pharmaceutical item, specifically a reservoir and a slim locking mechanism, to be delivered to the Charleston Consolidated Mail Outpatient Pharmacy (CMOP) facility. The procurement, identified by solicitation number 36C77025Q0092, requires a total quantity of 6,250 units packaged in 10-count boxes, and is categorized as a Small Business Set-Aside under NAICS Code 325413. This procurement is vital for ensuring the availability of necessary pharmaceutical supplies, adhering to federal regulations, and promoting small business participation in government contracting. Interested vendors must submit their proposals, including required documentation, by February 14, 2025, at 3 PM Central Time, and can direct inquiries to Contract Specialist Jennifer Coleman at Jennifer.Coleman4@va.gov or by phone at 913-758-9934.
    6505--Mycophenolate Mofetil RFP
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Mycophenolate Mofetil capsules and tablets under its Pharmaceutical Prime Vendor Program. The objective of this contract is to establish national pricing for these pharmaceutical products to meet the needs of various government health care facilities, including those under the Department of Defense and Indian Health Service. These medications are critical for patient care within federal health systems, necessitating compliance with FDA standards and the Drug Supply Chain Security Act to ensure safe and reliable distribution. Interested vendors should contact Contract Specialist Amber Zavala at amber.zavala@va.gov for further details, and proposals must include pricing for the base year and four option years as outlined in the solicitation document.
    6505--Tamsulosin Capsules
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Tamsulosin Hydrochloride capsules as part of its Pharmaceutical Prime Vendor (PPV) Programs. Offerors are required to submit pricing for a base year and four option years, ensuring compliance with FDA standards and providing a unique 11-digit National Drug Code (NDC) for each product. This procurement is vital for maintaining a consistent supply of necessary pharmaceuticals to federal healthcare facilities, adhering to regulatory standards while ensuring availability and pricing stability. Interested parties must submit their offers by February 24, 2025, at 2:30 PM CST, and can contact Contract Specialist Andrew J. Cazares at Andrew.Cazares@va.gov for further information.
    6505--766_Pharmaceuticals_VA CMOP Charleston_36C77025Q0119 766-25-2-400-0356 -Charleston CMOP AZELASTINE/NASAL -(VA-25-00038798)
    Buyer not available
    The Department of Veterans Affairs is seeking suppliers for the procurement of Azelastine nasal inhalation spray under solicitation number 36C77025Q0119. This opportunity is specifically aimed at small businesses and requires vendors to submit their quotes electronically by February 20, 2025, along with necessary documentation such as a signed SF1449 form and a state wholesale distributor license, in compliance with the Drug Supply Chain Security Act. The procurement emphasizes the importance of safety and regulatory adherence in pharmaceuticals, with products expected to be delivered within ten days after award, which is anticipated on February 24, 2025. Interested parties should contact Jeffrey A Blackard at jeffrey.blackard@va.gov for further information.
    6505--764-25-2-077-0483 -Murfreesboro CMOP Eyelid Cleanser -(VA-25-00042430)
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of Eyelid Cleanser Eye Scrub Pads for the Murfreesboro Consolidated Mail Outpatient Pharmacy (CMOP). This solicitation, identified as contract number 36C77025Q0136, requires vendors to provide essential pharmaceutical supplies while adhering to strict compliance with federal regulations, including the Drug Supply Chain Security Act. The Eyelid Cleanser is a critical medical product aimed at ensuring the health and well-being of veterans, necessitating high standards of quality and traceability. Interested vendors must submit their quotes by February 19, 2025, at 3:00 PM Central Time, along with required documentation such as a signed SF1449 cover page, pricing schedule, and proof of compliance with the Buy American Act. For further inquiries, vendors can contact Contract Specialist Jennifer D. Coleman at jennifer.coleman4@va.gov.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    6505--Bevacizumab Injection
    Buyer not available
    The Department of Veterans Affairs (VA) intends to procure Bevacizumab Injections through a Request for Proposal (RFP) designated as 36E79725R0019. This procurement aims to secure an uninterrupted supply of Bevacizumab, a critical pharmaceutical product used in the treatment of various medical conditions, for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The contract will span one year with four additional one-year option periods, and the estimated annual requirements include various package sizes of Bevacizumab, with a total estimated usage of over 100,000 vials. Interested offerors must submit their proposals by March 4, 2025, at 2:30 PM Central Time, and can direct inquiries to Contract Specialist Matthew Poulin at Matthew.Poulin@va.gov or by phone at 708-786-5186.
    6505--Fluticasone Propionate 50 MCG/Spray Soln, Nasal, 16GM
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Fluticasone Propionate 50 MCG/Spray solution, nasal, 16GM, intended for use by various federal agencies including the Department of Defense, Bureau of Prisons, and Indian Health Service. The objective of this procurement is to secure a reliable and uninterrupted supply of this medication for a contract period of one year, with the possibility of four additional one-year extensions. This medication is crucial for treating nasal conditions, and the estimated annual requirement is approximately 5,784,828 bottles. The solicitation will be available electronically on or around February 11, 2025, with a closing date set for February 25, 2025. Interested vendors should direct inquiries to Michael Olszewski at michael.olszewski@va.gov or call 708-786-4966.
    6505--Phenytoin SA Capsules (VA-25-00022318)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the supply of Phenytoin Sodium (NA) Extended 100MG Sustained Action Capsules under the contract number VA-25-00022318. This procurement aims to secure a reliable source of essential medications for the VA and Department of Defense’s Pharmaceutical Prime Vendor Programs, with a contract structure that includes a base year and four option years, along with a mandatory 0.5% Cost Recovery Fee. Compliance with federal regulations, including the Drug Supply Chain Security Act (DSCSA) and FDA Good Manufacturing Practices (cGMP), is critical, as is the submission of unique 11-digit National Drug Code (NDC) numbers and a Letter of Commitment from manufacturers by distributors. Interested parties should contact Contract Specialist Youlanda Duggar at youlanda.duggar@va.gov for further details and to ensure compliance with the submission requirements.
    6505--Rituximab and Biosimilars
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Rituximab 10mg/ml and its biosimilars, aimed at establishing a reliable pharmaceutical supply source for government healthcare facilities. Bidders are required to provide unique National Drug Code (NDC) numbers for their products and include a 0.5% Cost Recovery Fee in their pricing, with the contract covering a base year and four optional subsequent years. This procurement is critical for ensuring consistent product availability and pricing based on estimated annual usage, while adhering to FDA regulations and the Drug Supply Chain Security Act (DSCSA) for safety and traceability. Interested suppliers must submit their proposals by March 11, 2025, at 2:30 PM CT, and can contact Contract Specialist Deborah S Fassl at Deborah.Fassl@va.gov for further information.